U.S. Markets closed


NasdaqGS . Currency in USD
Add to watchlist
Interactive chart
Previous CloseN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Investor's Business Daily2 years ago

    Superbugs Turn Big Pharma, Gov't Focus To Antibiotics

    Late last month, the Obama administration rolled out a five-point plan to combat drug-resistant bacteria, which it said causes 2 million infections and 23,000 deaths in the U.S. alone every year. A report ...

  • GuruFocus.com2 years ago

    Mario Gabelli's Top 5 Stock Picks

    Mario Gabelli (Trades, Portfolio) is the founder of GAMCO Investors, a firm with $49.9 billion in assets under management across a range of funds.

  • Market Realist2 years ago

    Farallon Capital Starts New Position in Cubist Pharmaceuticals

    In December, the FDA approved Zerbaxa, Cubist's antibiotic that combats urinary tract infections and intra-abdominal infections in adults around the world.